Plus Therapeutics logo

Plus Therapeutics Share Price (NASDAQ: PSTV)

$0.49

-0.02

(-3.92%)

Live

Last updated on

Check the interactive Plus Therapeutics Stock chart to analyse performance

Plus Therapeutics stock performance

as on August 28, 2025 at 12:42 am IST

  • Today's Low:$0.49
    Today's High:$0.51

    Day's Volatility :3.66%

  • 52 Weeks Low:$0.16
    52 Weeks High:$2.31

    52 Weeks Volatility :92.93%

Plus Therapeutics Stock Returns

PeriodPlus Therapeutics IncIndex (Russel 2000)
3 Months
83.88%
0.0%
6 Months
-33.95%
0.0%
1 Year
-65.67%
0.0%
3 Years
-96.65%
-6.9%

Plus Therapeutics Inc Key Stats

Check Plus Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.51
Open
$0.5122
Today's High
$0.5054
Today's Low
$0.4869
Market Capitalization
$48.2M
Today's Volume
$8.4M
52 Week High
$2.3099
52 Week Low
$0.1634
Revenue TTM
$5.3M
EBITDA
$-12.2M
Earnings Per Share (EPS)
$-1.39
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-522.5%

Stock Returns calculator for Plus Therapeutics Stock including INR - Dollar returns

The Plus Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Plus Therapeutics investment value today

Current value as on today

₹38,235

Returns

₹61,765

(-61.77%)

Returns from Plus Therapeutics Stock

₹66,438 (-66.44%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Plus Therapeutics Stock

17.44%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Investment in Plus Therapeutics Shares from India has grown by 17.44% over the past 30 days, indicating increased transactional activity.

-11%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Plus Therapeutics Stock from India on INDmoney has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Plus Therapeutics Inc

  • Name

    Holdings %

  • HRT FINANCIAL LLC

    0.11%

  • Susquehanna International Group, LLP

    0.09%

  • Geode Capital Management, LLC

    0.06%

  • Virtu Financial LLC

    0.04%

  • UBS Group AG

    0.04%

  • Vanguard Group Inc

    0.04%

Analyst Recommendation on Plus Therapeutics Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Plus Therapeutics(by analysts ranked 0 to 5 stars)

Plus Therapeutics Share Price Target

What analysts predicted

Upside of 1702.71%

Target:

$8.83

Current:

$0.49

Plus Therapeutics share price target is $8.83, a slight Upside of 1702.71% compared to current price of $0.49 as per analysts' prediction.

Plus Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, PSTV stock has moved up by 72.4%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.05M → 1.39M (in $), with an average increase of 23.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -17.40M → 5.15M (in $), with an average increase of 437.8% per quarter
  • PSTV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.0% return, outperforming this stock by 126.7%
  • PSTV vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 210.1%
  • Price to Sales

    ForPSTV every $1 of sales, investors are willing to pay $1.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.7 for every $1 of sales.

Plus Therapeutics Technicals Summary

Sell

Neutral

Buy

Plus Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Plus Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Plus Therapeutics Inc logo
-13.4%
-33.95%
-65.67%
-96.65%
-98.62%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.9%
-51.12%
-0.89%
-2.51%
Beone Medicines Ltd logo
4.54%
18.87%
52.28%
84.02%
26.72%
Vertex Pharmaceuticals Incorporated logo
-16.02%
-19.22%
-19.42%
37.43%
43.36%
Alnylam Pharmaceuticals, Inc. logo
38.9%
84.99%
60.96%
115.82%
243.29%

About Plus Therapeutics Inc

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is REYOBIQ, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests, such as the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas.
Organization
Plus Therapeutics
Employees
21
CEO
Dr. Marc H. Hedrick M.B.A., M.D.
Industry
Health Technology

Key Management of Plus Therapeutics Inc

NameTitle
Dr. Marc H. Hedrick M.B.A., M.D.
President, CEO & Director
Mr. Andrew J. Sims CPA
VP of Finance & CFO
Dr. Michael Stanley Rosol Ph.D.
Chief Development Officer
Ms. Desiree Smith
Corporate Controller
Mr. Russell W. Bradley
President & GM of CNSide Diagnostics

Important FAQs about investing in PSTV Stock from India :

What is Plus Therapeutics share price today?

Plus Therapeutics share price today is $0.49 as on . Plus Therapeutics share today touched a day high of $0.51 and a low of $0.49.

What is the 52 week high and 52 week low for Plus Therapeutics share?

Plus Therapeutics share touched a 52 week high of $2.31 and a 52 week low of $0.16. Plus Therapeutics stock price today i.e. is trending at $0.49, lower by 78.79% versus the 52 week high.

How to invest in Plus Therapeutics Stock (PSTV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Plus Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Plus Therapeutics Shares that will get you 3.0612 shares as per Plus Therapeutics share price of $0.49 per share as on August 28, 2025 at 12:42 am IST.

What is the minimum amount required to buy Plus Therapeutics Stock (PSTV) from India?

Indian investors can start investing in Plus Therapeutics (PSTV) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Plus Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Plus Therapeutics share’s latest price of $0.49 as on August 28, 2025 at 12:42 am IST, you will get 20.4082 shares of Plus Therapeutics. Learn more about fractional shares .

What are the returns that Plus Therapeutics has given to Indian investors in the last 5 years?

Plus Therapeutics stock has given -98.62% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?